Related Experiment Video
Updated: Apr 11, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Amphotericin B Resistance in Aspergillus terreus Is Overpowered by Coapplication of Pro-oxidants
Michael Blatzer1, Emina Jukic1, Wilfried Posch1
11 Division of Hygiene and Medical Microbiology, Medical University of Innsbruck , Innsbruck, Austria .
Aims:
Invasive fungal infections have significantly increased over the past decades in immunocompromised individuals and high-risk patients. Amphotericin B (AmB) exerts a powerful and broad activity against a vast array of fungi and has a remarkably low rate of microbial resistance. However, most isolates of Aspergillus terreus developed an intrinsic resistance against AmB, and during this study, we characterized the mode of action of this polyene antifungal drug in more detail in resistant (ATR) and rare susceptible (ATS) clinical isolates of A. terreus.
Results:
We illustrate that AmB treatment changes cellular redox status and promotes the generation of high levels of reactive oxygen species (ROS) in ATS. In contrast, ATR isolates were able to cope better with AmB-induced oxidative stress.
Innovation:
Most importantly, we demonstrate in this study that coapplication of anti- and pro-oxidants significantly affects AmB efficacy in an antithetic manner--antioxidants and ROS-scavenging agents increase AmB tolerance in susceptible strains, while pro-oxidants render formerly resistant isolates considerably susceptible to the antifungal drug also in vivo in a Galleria animal model.
Conclusion:
Thereby, our study provides novel therapeutic options to treat formerly resistant fungal strains by a combination of AmB and pro-oxidant compounds.
Insights
Amphotericin B (AmB) effectiveness against resistant Aspergillus terreus can be restored. Combining AmB with pro-oxidants, which promote reactive oxygen species (ROS), overcomes fungal resistance, offering new treatment strategies.
Area of Science:
- Mycology
- Antifungal Drug Discovery
- Antimicrobial Resistance
Background:
- Invasive fungal infections are increasing in immunocompromised patients.
- Amphotericin B (AmB) is a potent antifungal with low resistance rates.
- Aspergillus terreus often exhibits intrinsic resistance to AmB.
Purpose of the Study:
- To investigate the mechanism of AmB action in resistant (ATR) and susceptible (ATS) Aspergillus terreus.
- To explore strategies for overcoming AmB resistance in A. terreus.
Main Methods:
- Characterization of AmB's mode of action in resistant and susceptible A. terreus isolates.
- Assessment of cellular redox status and reactive oxygen species (ROS) generation.
- Evaluation of AmB efficacy in combination with antioxidants and pro-oxidants in vitro and in vivo (Galleria model).
Main Results:
- AmB induces ROS generation in susceptible A. terreus strains.
- Resistant A. terreus isolates better manage AmB-induced oxidative stress.
- Antioxidants increase AmB tolerance in susceptible strains, while pro-oxidants restore AmB susceptibility in resistant strains.
Conclusions:
- AmB efficacy is modulated by cellular oxidative stress.
- Combining AmB with pro-oxidants represents a novel therapeutic approach to treat AmB-resistant fungal infections.
- This strategy offers potential for treating resistant Aspergillus terreus infections.
More Related Videos
09:21Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.
Published on: February 15, 2019
12:29Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Related Concept Videos
Antifungal Agents
Fungal Phylum Ascomycota
Clinical Significance of Antibiotic Resistance